Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments - Summary of Stock Options Activity (Details)

v3.20.2
Share-Based Payments - Summary of Stock Options Activity (Details)
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Shares, Beginning Balance | shares 40
Number of Shares, Granted | shares
Number of Shares, Exercised | shares
Number of Shares, Forfeited | shares (40)
Number of Shares, Canceled/Expired | shares
Number of Shares, Ending Balance | shares
Number of Shares, Exercisable | shares
Weighted Average Exercise Price, Beginning Balance $ 236.16
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited 236.16
Weighted Average Exercise Price, Canceled/Expired
Weighted Average Exercise Price, Ending Balance
Weighted Average Exercise Price, Exercisable
Weighted Average Grant Date Fair Value, Beginning 151.68
Weighted Average Grant Date Fair Value, Granted
Weighted Average Grant Date Fair Value, Exercised
Weighted Average Grant Date Fair Value, Forfeited 151.68
Weighted Average Grant Date Fair Value, Canceled/Expired
Weighted Average Grant Date Fair Value, Ending
Weighted Average Grant Date Fair Value, Exercisable
Weighted Average Remaining Contractual Term (Years), Beginning 11 months 26 days
Weighted Average Remaining Contractual Term (Years), Granted 0 years
Weighted Average Remaining Contractual Term (Years), Exercised 0 years
Weighted Average Remaining Contractual Term (Years), Forfeited 2 months 27 days
Weighted Average Remaining Contractual Term (Years), Canceled/Expired 0 years
Weighted Average Remaining Contractual Term (Years), Ending 0 years
Weighted Average Remaining Contractual Term (Years), Exercisable 0 years
Aggregate Intrinsic Value, Beginning Balance | $
Aggregate Intrinsic Value, Ending Balance | $
Aggregate Intrinsic Value, Exercisable | $